MedPath

Nanjing Medical University First Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

Completed
Conditions
Type2 Diabetes
First Posted Date
2018-05-09
Last Posted Date
2018-05-11
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
250
Registration Number
NCT03519529

Influence of Injection Technique of Premixed Insulin on Glucose Excursion in Type 2 Diabetes Mellitus

Not Applicable
Conditions
Type2 Diabetes Mellitus
Interventions
Other: nurse inject premixed insulin
First Posted Date
2018-05-01
Last Posted Date
2018-05-11
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
60
Registration Number
NCT03513055

BIS of Sedation Depth During Flexible Bronchoscopy.

Not Applicable
Conditions
Pulmonary Disease
Interventions
Device: Bispectral Index monitoring
First Posted Date
2018-01-10
Last Posted Date
2018-01-10
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
500
Registration Number
NCT03395093

The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis

Not Applicable
Completed
Conditions
Sepsis
Enteral Feeding
Immune System Disorder
Interventions
Other: enteral nutrition
First Posted Date
2017-12-29
Last Posted Date
2019-03-05
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
53
Registration Number
NCT03385850
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

Completed
Conditions
Type2 Diabetes
First Posted Date
2017-12-05
Last Posted Date
2022-04-14
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
1713
Registration Number
NCT03362112

Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension

Not Applicable
Completed
Conditions
Pulmonary Arterial Hypertension
Interventions
Procedure: Sham operation
Procedure: PADN
First Posted Date
2017-09-13
Last Posted Date
2022-03-29
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
128
Registration Number
NCT03282266
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2017-07-21
Last Posted Date
2017-07-21
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
110
Registration Number
NCT03226210
Locations
🇨🇳

Nanjing First Hostital, Nanjing, Jiangsu, China

Optical Coherence Tomography (OCT) Findings and Coronary Bifurcation Lesions

Not Applicable
Completed
Conditions
Coronary Bifurcation Lesions
Interventions
Procedure: percutaneous coronary intervention
First Posted Date
2017-06-01
Last Posted Date
2019-07-30
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Target Recruit Count
304
Registration Number
NCT03172845
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Phase 3
Withdrawn
Conditions
Diabetic Kidney Disease
Interventions
Other: Sham Comparator
First Posted Date
2017-04-07
Last Posted Date
2020-11-09
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Registration Number
NCT03105219
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI

Phase 3
Withdrawn
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2017-03-13
Last Posted Date
2021-08-19
Lead Sponsor
Nanjing First Hospital, Nanjing Medical University
Registration Number
NCT03078465
Locations
🇨🇳

Nanjing First Hospital, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath